432 related articles for article (PubMed ID: 14567189)
1. Response of melanoma tumor phospholipid metabolism to chloroethyle nitrosourea: a high resolution proton NMR spectroscopy study.
Morvan D; Demidem A; Madelmont JC
Pathol Biol (Paris); 2003 Jul; 51(5):256-9. PubMed ID: 14567189
[TBL] [Abstract][Full Text] [Related]
2. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples.
Morvan D; Demidem A; Papon J; De Latour M; Madelmont JC
Cancer Res; 2002 Mar; 62(6):1890-7. PubMed ID: 11912170
[TBL] [Abstract][Full Text] [Related]
3. Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl nitrosourea: demonstration of phospholipid metabolism alterations.
Morvan D; Demidem A; Papon J; Madelmont JC
Magn Reson Med; 2003 Feb; 49(2):241-8. PubMed ID: 12541243
[TBL] [Abstract][Full Text] [Related]
4. Combined methionine deprivation and chloroethylnitrosourea have time-dependent therapeutic synergy on melanoma tumors that NMR spectroscopy-based metabolomics explains by methionine and phospholipid metabolism reprogramming.
Guénin S; Morvan D; Thivat E; Stepien G; Demidem A
Nutr Cancer; 2009; 61(4):518-29. PubMed ID: 19838924
[TBL] [Abstract][Full Text] [Related]
5. [The effect of antitumor preparations on the energy metabolism of melanoma B16 in mice. A 31P-NMR method in vivo].
Shkarin PIu; Sokolova IS; Gorbacheva LB; Sibel'dina LA
Dokl Akad Nauk SSSR; 1989; 309(4):996-9. PubMed ID: 2635671
[No Abstract] [Full Text] [Related]
6. Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model.
Demidem A; Morvan D; Papon J; De Latour M; Madelmont JC
Cancer Res; 2001 Mar; 61(5):2294-300. PubMed ID: 11280801
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways.
Morvan D; Demidem A
Cancer Res; 2007 Mar; 67(5):2150-9. PubMed ID: 17332345
[TBL] [Abstract][Full Text] [Related]
8. CENU treatment induced bystander effects which are effective on parental and non-parental tumors and have a phospholipid metabolism proton NMR spectroscopy signature.
Merle P; Morvan D; Madelmont JC; Caillaud D; Demidem A
Int J Oncol; 2006 Sep; 29(3):637-42. PubMed ID: 16865279
[TBL] [Abstract][Full Text] [Related]
9. Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: a 31P nuclear magnetic resonance study in vivo and in vitro.
Bhujwalla ZM; Aboagye EO; Gillies RJ; Chacko VP; Mendola CE; Backer JM
Magn Reson Med; 1999 May; 41(5):897-903. PubMed ID: 10332871
[TBL] [Abstract][Full Text] [Related]
10. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
[TBL] [Abstract][Full Text] [Related]
11. Synthetic phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase.
Ferreira AK; Meneguelo R; Marques FL; Radin A; Filho OM; Neto SC; Chierice GO; Maria DA
Biomed Pharmacother; 2012 Oct; 66(7):541-8. PubMed ID: 22902646
[TBL] [Abstract][Full Text] [Related]
12. A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver.
Bell JD; Cox IJ; Sargentoni J; Peden CJ; Menon DK; Foster CS; Watanapa P; Iles RA; Urenjak J
Biochim Biophys Acta; 1993 Nov; 1225(1):71-7. PubMed ID: 8241291
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced bystander effect in response to several chloroethylnitrosoureas: an origin independent of DNA damage?
Merle P; Morvan D; Caillaud D; Demidem A
Anticancer Res; 2008; 28(1A):21-7. PubMed ID: 18383820
[TBL] [Abstract][Full Text] [Related]
14. Cirrhosis of the human liver: an in vitro 31P nuclear magnetic resonance study.
Taylor-Robinson SD; Thomas EL; Sargentoni J; Marcus CD; Davidson BR; Bell JD
Biochim Biophys Acta; 1995 Oct; 1272(2):113-8. PubMed ID: 7548234
[TBL] [Abstract][Full Text] [Related]
15. G2 accumulation and melanin overproduction in malignant melanocytes treated with a new nitrosourea.
Buchdahl C; Papon J; Communal Y; Bourges M; Madelmont JC
Melanoma Res; 1998 Dec; 8(6):517-27. PubMed ID: 9918414
[TBL] [Abstract][Full Text] [Related]
16. Tumour phospholipid metabolism.
Podo F
NMR Biomed; 1999 Nov; 12(7):413-39. PubMed ID: 10654290
[TBL] [Abstract][Full Text] [Related]
17. [Antitumor activity of several new pentopyranosyl-chloroethylnitrosoureas].
Grouiller A; Navarro ML; Nonga B; Molière P; Santini R; Voulot C; Pacheco H
C R Seances Soc Biol Fil; 1987; 181(2):128-36. PubMed ID: 2957032
[TBL] [Abstract][Full Text] [Related]
18. Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.
Esmaeili M; Bathen TF; Engebråten O; Mælandsmo GM; Gribbestad IS; Moestue SA
Magn Reson Med; 2014 Jun; 71(6):1973-81. PubMed ID: 23878023
[TBL] [Abstract][Full Text] [Related]
19. Effect of cell density on cytotoxicity of ether lipid analogues in variants of B16 murine melanoma.
Trulla LL; Magistrelli A; Salmona M; Tacconi MT
Lipids; 1993 May; 28(5):403-6. PubMed ID: 8316047
[TBL] [Abstract][Full Text] [Related]
20. A model of phospholipid biosynthesis in tumor in response to an anticancer agent in vivo.
Behzadi M; Demidem A; Morvan D; Schwartz L; Stepien G; Steyaert JM
J Integr Bioinform; 2010 Mar; 7(3):. PubMed ID: 20375456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
